A novel CAR T-cell therapy, GCC19CART, has demonstrated activity in patients with heavily pretreated, metastatic colorectal cancer.

(HealthDay News) — Among cancer survivors, excess body weight is associated with an increased risk of a second primary cancer, according to a study published in JAMA Network Open.

Receiving an mRNA COVID-19 vaccine within 100 days of starting ICI therapy may improve overall survival in some cancer patients.

Source: Getty Images ESMO 2024 featured studies that may change clinical practice for a range of cancers as well as studies that highlight the need for new approaches to cancer treatment.

The FDA has approved Keytruda (pembrolizumab) in combination with chemotherapy as first-line treatment for adults with malignant pleural mesothelioma.

The US Food and Drug Administration (FDA) has approved a 420 mg dosage strength of Hercessi (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab). Hercessi, a HER2/neu receptor antagonist, is ...

Breastfeeding appears feasible and safe for breast cancer survivors with BRCA1/2 mutations or hormone receptor-positive disease ...

Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Breast cancer is the most common cancer in women in the United States.